Escalon Medical (OTCMKTS:ESMC – Get Free Report) posted its quarterly earnings results on Tuesday. The medical equipment provider reported $0.12 earnings per share for the quarter, Zacks reports. The company had revenue of $3.86 million during the quarter. Escalon Medical had a negative return on equity of 21.42% and a net margin of 16.17%.
Escalon Medical Trading Up 6.1%
Shares of OTCMKTS ESMC opened at $0.17 on Thursday. The business has a 50 day simple moving average of $0.17 and a 200 day simple moving average of $0.18. Escalon Medical has a 52 week low of $0.14 and a 52 week high of $0.28. The stock has a market cap of $1.30 million, a price-to-earnings ratio of 1.50 and a beta of 0.51. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.94 and a current ratio of 2.59.
About Escalon Medical
Escalon Medical Corp. is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.
Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.
Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally.
See Also
- Five stocks we like better than Escalon Medical
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
